Bristol-Myers Squibb plans 113 job cuts in southern Indiana
Drugmaker Bristol-Myers Squibb Co. plans to close one of its southern Indiana facilities and cut jobs at another.
Health Care & Insurance
Articles
Lilly reports $942 million profit in third quarter
Excluding special items, Eli Lilly and Co.’s earnings per share spike 22 percent on the strength of Alimta, Cymbalta and Humalog
sales. Lilly’s revenue rose 7 percent in the quarter over the same period of 2008,
to $5.56 billion.
Cook: Tax could kill 1,000 jobs in Bloomington
Bloomington-based Cook Group Inc. could find itself cutting as many as 1,000 local jobs if Congress enacts a tax on
medical devices to pay for health care reform, company founder Bill Cook said in an interview.
Medco plans to compare Plavix, Effient in study
Medco Health Solutions Inc. said Tuesday it will compare the blood thinner Plavix, the world’s second-best selling drug, with
Effient, a potential blockbuster drug sold by Indianapolis-based Eli Lilly and Co.
Cook calls for new approach to health reform
Founder of medical device firm says Congress should fund network of low-cost clinics.
Afraid to die
Fear of death may be causing Americans to expect too much from our medical system when it comes to prolonging the lives of
the old and infirm.
Manchester wants doctoral pharmacology program
Manchester College officials say they want to start a pharmacy school in Fort Wayne starting in the fall of 2012.
Endocyte receives $26M infusion from investors
West Lafayette-based Endocyte Inc. announced Friday that it has closed on $26 million in equity financing to help the company
continue developing cancer-fighting drugs.
State’s health IT groups seek stimulus funds
Some of Indiana’s leading organizations in health information technology are collaborating on an effort to receive several
million dollars of stimulus funding.
HICKS: Flu season offers prelude to health care reform
This flu season looks to provide us an inkling of the real dangers inherent in large-scale health care reform, most especially
a full-blown national health care option.
Baucus health reform bill draws fire in Indiana, too
The health insurance industry’s sudden counterpunch to the Senate version of health reform echoed in Indiana and
opened a key issue for the rest of the debate: Will covering half of the country’s uninsured mean raising premiums for
the 85 percent of Americans who already have insurance?
Power Breakfast panel debates health care reform
As health care legislation
continues to wend its way through Congress, Indianapolis-area industry leaders still harbor strong
opinions about the issue. Five industry insiders discussed how to improve the health care system during
IBJ’s Power Breakfast Sept. 25 at the Westin Indianapolis.
Tougher smoking ban passes committee
An ordinance that would prohibit lighting up in bars, bowling alleys and nightclubs, and nearby outdoor seating areas as well, was endorsed 4-2 by a City-County Council committee Wednesday night.
KALSCHEUR: Doctors eye precautions as reform gains steam
Doctors are considering their options as health care reform gains momentum.
German company to buy Eli Lilly’s Lafayette plant
Eli Lilly and Co. will sell its manufacturing plant in Lafayette to a German company in its first major move toward reducing its work force by 5,500 employees and cutting its operating expenses by $1 billion.
Doctors link together to experiment with ‘one-stop shopping’
Specialists are clustering to focus on a single ailment, such as pain, to cut costs and improve quality of treatment.
Planned Parenthood cuts jobs, closing health centers
Planned Parenthood of Indiana has cut 25 jobs and will close six health centers around the state as part of a restructuring
it attributed to a decline in federal funding.
Lilly to pay Idaho $13M in drug settlement
Idaho is getting $13 million as part of a settlement reached with Indianapolis-based Eli Lilly and Co. over its marketing of
anti-psychotic drug Zyprexa.
Conseco shares soar on hedge-fund investment
Shares of Carmel-based life insurer soared as much as 26 percent, to $6.30 apiece, in morning trading after New York-based
Paulson & Co. agreed to buy $78 million in Conseco stock and $200 million in company bonds.
Lilly to sell Lafayette plant to German firm
Nearly 700 workers will be offered severance, new jobs